Absorption and Excretion of a New Oral Antitumor Drug, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU), in Cancer Patients-Reference-Cited by-同舟云学术

Absorption and Excretion of a New Oral Antitumor Drug, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU), in Cancer Patients

Published:1980-06-01 Issue:1 Volume:10 Page:83-91
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

,Koyama Yasuo¹,Niitani Hisanobu¹,Maruyama Keiichi¹,Okabayashi Kenzo¹,Okazaki Nobuo¹,Takakura Kintomo¹,Sakano Teruo¹,Ise Toru¹,Koyama Yoshiyuki²,Kimura Tadashi²,Imamura Yukio²,Nakajima Osamu²,Umeda Noritsugu²,Sakagami Ryuichi²,Saito Tatuo³,Nakao Isao³,Kanko Takao³,Oh-hashi Yasuhiko³,Ogawa Makoto³,Inoue Yukoh³,Yokoyama Masakazu⁴,Kusama Satoru⁵,Tomiyama Jiro⁵,Itoh Ichiji⁶,Sakai Yasunobu⁶,Kubo Akira⁶,Tominaga Takeshi⁶,Ishiwata Jun-ichi⁶,Hara Yoshio⁷,Takatani Osamu⁸,Ohta Kazuo⁸,Murakami Minoru⁹,Taguchi Tetsuo¹⁰,Nakano Yosuke¹⁰,Jikuya Kozo¹⁰,Inoguchi Kiyoshi¹¹,Kumashiro Ryunosuke¹¹,Tamada Ryuichiro¹¹

Affiliation:

1. National Cancer Center Hospital

2. National Medical Center Hospital

3. Cancer Institute and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

4. Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University

5. Faculty of Medicine, University of Tokyo

6. Tokyo Metropolitan Komagome Hospital

7. Tokyo Metropolitan Ebara Hospital

8. National Defense Medical College Hospital

9. Aichi Cancer Center Hospital

10. Research Institute for Microbial Disease, Osaka University

11. Faculty of Medicine, Kyushu University